FMP
NASDAQ
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
7.77 USD
0.12 (1.54%)
Valuation Date:
May 2, 2024 4:00 PM
Share Price on Valuation Date
$7.77
Stock Beta
0.352
Shares Outstanding
49533016